Team Approach to Translate Novel Biomarkers for Diabetes

Medicine & Life Sciences

1. 2,4-thiazolidinedione 39%
2. Amputation 27%
3. Atherosclerosis 22%
4. Biomarkers 100%
5. Blindness 28%
6. Blood Glucose 46%
7. Cardiovascular Diseases 20%
8. Cause of Death 22%
9. Chronic Kidney Failure 24%
10. Clinical Trials 18%
11. Computational Biology 26%
12. Costs and Cost Analysis 17%
13. Diabetes Complications 56%
14. Diet Therapy 32%
15. Dipeptidyl-Peptidase IV Inhibitors 36%
16. Disease Progression 22%
17. Drug Therapy 16%
18. Exercise 18%
19. Glucagon-Like Peptide 1 32%
20. Health 13%
21. Health Care Costs 25%
22. Health Expenditures 28%
23. Hemoglobins 22%
24. Life Style 22%
25. Long-Acting Insulin 41%
26. Lower Extremity 22%
27. Metformin 30%
28. Mortality 14%
29. Neoplasms 9%
30. Ocular Vision 46%
31. Pandemics 29%
32. Pharmaceutical Preparations 69%
33. Population 10%
34. Proteins 10%
35. Quality of Life 17%
36. Rosiglitazone 35%
37. Sitagliptin Phosphate 39%
38. Technology Transfer 40%
39. Therapeutics 27%
40. Type 2 Diabetes Mellitus 83%
41. Urine 19%
42. Vildagliptin 43%
43. Weight Reduction Programs 37%